Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027627 (
metastases
)
103,950
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Fifteen patients with olfactory neuroblastoma were treated during the 17-year period of 1969 to 1986. Data was analyzed with respect to age at presentation, sex, presenting signs and symptoms, stage, and results of treatment. Age ranged from 4 to 67 years with the median age being 27 years. Median follow-up was 8 years. Local control was achieved in nine of nine patients or 100% with successful surgical resection, i.e., minimal residual disease, followed by postoperative radiation therapy (45 to 65 Gy) was employed. There were no distant failures when the primary site was controlled. Regional lymph node
metastases
were infrequent: only 13% (two of 15 patients) presented with positive nodes. Three of four patients treated initially with surgery alone had a local recurrence, two of which were successfully salvaged by combined therapy. There were four patients treated with radiation therapy alone: three had persistent disease after radiation therapy, and one patient was controlled with 65 Gy.
Olfactory neuroblastoma
has a propensity to recur locally when treated with surgery alone. The authors' experience suggests excellent local control can be achieved with surgery immediately followed by radiation therapy. Thus the authors recommend planned combined treatment for all resectable lesions.
...
PMID:Olfactory neuroblastoma. 272 May 89
The olfactory neuroblastoma or
esthesioneuroblastoma
is a rare neuroectodermal tumor originating from the olfactory neuroepithelium, which can metastasis via cerebrospinal fluid pathways. In the present case of an extensive nasal malignancy with cervical lymph node
metastases
in a 75-year old woman, its difficult histology alternatively led to a diagnosis of anaplastic carcinoma and non-Hodgkin lymphoma. The patient died from complications following spread of the tumor to the spinal cord and cauda equina. Review of the literature shows that this tumor is notorious for its chameleonic character. In view of its clearly demonstrated malignancy an aggressive therapeutic approach is advocated.
...
PMID:Olfactory neuroblastoma with spinal metastasis--a problem in diagnosis. 302 77
A case of
esthesioneuroepithelioma
was investigated ultrastructurally and immunohistochemically, using antibodies against neurofilament protein (NFP), glial fibrillary acidic protein (GFAP), keratin, neuron-specific enolase (NSE), S-100 protein (S-100), and tyrosine hydroxylase (TH). The tumor initially manifested as an epidural mass in the anterior cranial fossa in a 64-year-old man, and about 3 1/2 years later, autopsy further revealed extensive
metastases
to the lymph nodes of the neck and thoracic cavity. In the cranial and nasal cavities, the tumor was composed of fairly uniform, ill-defined cells arranged in nests which were surrounded by a fibrovascular stroma. These histological features were reproduced in the metastatic tumor nodules with frequent occurrence of tubular arrangements of the tumor cells. Ultrastructurally, two different cell types were well recognized by their characteristic morphological features, which were reminiscent of sensory neurons and sustentacular cells of the olfactory epithelium. No dense-cored secretory granules were observed in the tumor cells. Immunohistochemically, the tumor showed a variable number of cells positive for NFP, keratin, NSE and S-100. NFP was present in a relatively small number of cells, which were found diffusely in the nests. Keratin was observed in the cells mainly located at the periphery. NSE-positive cells tended to form irregular clusters in the center. A few S-100-positive cells were found, without any particular arrangement.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Esthesioneuroepithelioma: a tumor of true olfactory epithelium origin. An ultrastructural and immunohistochemical study. 343 22
Esthesioneuroblastoma
is an uncommon nasal neoplasm of neural crest origin, which is recognized for its propensity for local recurrence and distant dissemination by both lymphatic and hematogenous routes. Hematogenous spread occurs most frequently to the lungs and bones, but
metastases
to the liver, spleen, scalp, face, breast, adrenal, aorta, and ovary have been reported. We present a patient who developed metastatic
esthesioneuroblastoma
of the trachea 1 year after successful craniofacial resection of his primary tumor. The patient was treated by YAG laser resection of the metastatic tumor followed by radiotherapy. He was free of tracheal disease 1 year after treatment of the
metastases
.
...
PMID:Esthesioneuroblastoma metastatic to the trachea. 350 17
The current state of electronmicroscopy in research and clinical applications in otorhinolaryngology is reviewed. The recognition of cytoarchitectonic relationships by means of transmission electronmicroscopy, tracer studies and freeze fracture technique provides functionally interesting findings on the sensory epithelium and the permeability barriers of the inner ear. Knowledge of the fine structure of the animal and human ear also facilitates the understanding of the pathomechanism of the inner ear. Experimental and clinical findings of seromucotympanon are also described, as well as the morphology of normal and diseased respiratory mucosa. A viral origin for laryngeal papilloma is clearly confirmed. New findings in the pathohistology of otosclerosis are described. Finally, the use of electronmicroscopy in the diagnosis of ENT tumours is considered. The demonstration of pathognomonic cell organelles is useful not only in the diagnosis of rare tumours, e.g.
esthesioneuroblastoma
or carcinoid. The epithelial origin of anaplastic tumours can also be shown or excluded. Electronmicroscopy also offers important clues in the case of neck
metastases
from an unknown primary tumour.
...
PMID:[The importance of electron microscopy in research and clinical otorhinolaryngology]. 355 89
Esthesioneuroblastoma
, a tumor of neural crest origin arising in the nasal cavity, is uncommon, may be difficult to diagnose, and frequently is not cured. We report a case that was originally diagnosed as an inflammatory polyp and recurred with extension into the anterior cranial fossa. Surgery and radiotherapy were followed by local recurrence and cerebrospinal fluid rhinorrhea. Despite initial negative results of investigation for
metastases
, recurrence appeared in cervical nodes and was followed by widespread bone, soft tissue, and cerebral metastasis. There was no response to multiple-agent chemotherapy. The results of surgery, radiation, and chemotherapy in this rare and lethal tumor are reviewed.
...
PMID:Esthesioneuroblastoma: cerebrospinal fluid rhinorrhea and widespread metastasis. 371 49
A retrospective review of the clinical records of 31 patients with
esthesioneuroblastoma
is presented. A bimodal age distribution was noted. The tumor is extremely rare among blacks. Most patients presented with locally advanced disease. However, regional and distant
metastases
at the time of initial diagnosis are uncommon. Local recurrence at the primary site was very common, and this reflects either the conservative initial surgical treatment employed or the multicentric nature of the tumor. Cervical lymph node metastasis is present in less than 10 percent of patients at the time of diagnosis. The survival rates were better in patients with early stages of disease. From this study, we conclude that the current management of these tumors should consist of a combination of radiation therapy and surgery. Radical resection followed by postoperative radiation therapy appears to be the treatment combination of choice. The five-year survival rate in our series was 52 percent.
...
PMID:Esthesioneuroblastoma. 640 23
We present the first case report of an olfactory neuroblastoma (
esthesioneuroblastoma
) diagnosed by cytologic examination. The patient was a 40-year-old male who had a 13-year history of "adenocarcinoma" of the nasal cavity until the correct diagnosis of olfactory neuroblastoma was made cytologically from pleural fluid shortly before his death. The cells had the typical features of rosette formation, scanty elongated cytoplasm, clustering of cells and nuclear compression resulting in an "onion-skin" appearance. Surgical specimens, several biopsies and fine needle aspiration of a metastatic deposit in a lymph node all showed, retrospectively, features of
esthesioneuroblastoma
. Electron microscopy showed membrane-bound dense-core secretory granules. Autopsy findings revealed multiple
metastases
but no tumor at the original site; that tumor had been treated with high-dose radiation therapy as well as systemic chemotherapy.
Olfactory neuroblastoma
is a rare tumor, but it is important to recognize because it has a better prognosis than the more commonly encountered malignancies of the nose.
...
PMID:Cytologic diagnosis of olfactory neuroblastoma. Report of a case with multiple diagnostic parameters. 657 48
A case of
esthesioneuroblastoma
, the pathological diagnosis of which almost always causes great difficulties, was investigated ultrastructurally, biochemically, and immunohistologically, using antibodies against the five known types of intermediate filaments [keratin, vimentin, desmin, glial fibrillary acidic protein (GFAP) and neurofilaments]. The tumour cells did not react with antibodies against any of the five intermediate filament proteins. Ultrastructural investigations showed dense cored secretory granules in the cytoplasm and cell processes. Thus, immunohistology offers by "exclusion" a differential diagnosis to avoid often misdiagnosed tumours (undifferentiated carcinomas, embryonal rhabdomyosarcomas, and malignant lymphomas), since carcinomas react with antikeratin, embryonal rhabdomyosarcomas with antibodies to desmin and malignant lymphomas show immunofluorescence with antibodies to vimentin. The biological behaviour (age distribution, tendency to
metastasize
), the normal values of biochemical parameters, homovanillic acid and vanilmandelic acid (HVA, VMA), and the absence of neurofilaments distinguish this type of tumour from the peripheral sympathetic neuroblastoma.
...
PMID:Esthesioneuroblastoma: ultrastructural, immunohistological and biochemical investigation of one case. 671 29
Three cases of neuroblastoma with intracranial
metastases
were reported. The first case was a 13-year-old girl with sacral neuroblastoma who had
metastases
to the left parietal bone and dura, and had bilateral intraorbital
metastases
. The second case was a 13-year-old girl with mediastinal neuroblastoma who had bilateral intraorbital
metastases
. The third case was a 49-year-old woman with
esthesioneuroblastoma
which had invaded to the dura at the right middle fossa and the right orbit. CT findings of the brain of these three cases were investigated, and summarized as follows: 1) The intracranial invasions of the metastatic tumors were seen to be slightly high density (EMI-number 25-27) in plain scans, and homogeneously enhanced as a well-defined high density mass (EMI-number 35-37). 2) The tumors invading the skull were observed as a mass lesion of the bone on osteolytic lesion. 3) The intraorbital metastatic tumors were seated on the orbital wall invading the rectal muscles, but they remained extraconal. It was emphasized that CT could give valuable information for the diagnosis of skull and intracranial metastasis of neuroblastoma.
...
PMID:[CT findings of skull and intracranial metastatic neuroblastoma--report of 3 cases (author's transl)]. 711 May 17
<< Previous
1
2
3
4
5
6
7
Next >>